Chinese researchers have shown that early insulin therapy can lower the incidence of stroke and heart failure-related hospitalization for newly diagnosed type 2 diabetes (T2D) patients as compared to those who have not received the medication; a report published in CGTN.
Type 2 diabetes mellitus is a group of dysfunctions that are typified by elevated blood glucose levels and are caused by a combination of insulin action resistance, insufficient insulin production, and excessive or incorrect glucagon secretion. Take a look at the picture below.
Researchers from the University of Science and Technology of China, Southern Medical University, Peking University, and Professor Weng Jianping of Anhui Medical University collaborated to conduct a 24-year observational study on the care of 5,424 T2D patients nationwide.
Read: Starfish that consume coral may benefit from global warming
They found that newly diagnosed T2D patients who underwent the therapy experienced a 31 percent reduced risk of stroke and a 28 percent lower risk of hospitalization due to heart failure.
This study also shows that early insulin treatment can help newly diagnosed T2D patients’ biomarkers for low-grade inflammation and endothelial function—both of which are established indications of cardiovascular risk.
This offers strong support for starting early insulin therapy as the first course of treatment for those who have just received a diagnosis.
Source(s): Xinhua News Agency
